Hepatocellular Carcinoma Stage III
4 clinical trials · Condition
◉ Watch Hepatocellular Carcinoma Stage III
| Record | Firm | Date |
|---|---|---|
| Brazilian Reality of Hepatocellular Carcinoma (NCT06230328) | AstraZeneca | 2024-04-15 |
| Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research (NCT06559761) | Chinese PLA General Hospital | 2023-01-01 |
| Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE (NCT05125094) | Shanghai Zhongshan Hospital | 2021-12-01 |
| Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma (NCT04961138) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-08-01 |
Track Hepatocellular Carcinoma Stage III automatically
Every clearance here is in the API, with alerts when new ones post.